Search is Powered by Google
Pharma Industry / Biotech Industry News

Industry Group Letter Indicates Qualified Support For Bill To Allow Approval Of Generic Biotechnology Medications

Main Category: Pharma Industry / Biotech Industry
Article Date: 20 May 2008 - 7:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The Biotechnology Industry Organization has issued a letter to Reps. Anna Eshoo (D-Calif.) and Joe Barton (R-Texas) to indicate qualified support for a bill (HR 5629) that they have introduced to allow FDA to approve generic biotech medications, CQ HealthBeat reports (McCarthy, CQ HealthBeat, 5/16).

The legislation would provide brand-name biotech companies with at least 12 years of market exclusivity before generic versions of their medications could reach the market. In addition, the bill would require clinical trials for generic versions of biotech medications, although FDA could waive the requirement. Under the bill, FDA could classify generic versions of biotech medications as interchangeable with brand-name versions at pharmacies, provided that the agency has developed guidance on the evidence required to prove interchangeability for a product class (Kaiser Daily Health Policy Report, 3/17).

In the letter, BIO President and CEO Jim Greenwood wrote that the group supports the legislation but seeks an increase in the period of market exclusivity from 12 to 14 years to encourage the development of new biotech medications. "Data exclusivity is absolutely necessary to preserve incentives for innovation," he wrote, adding, "A follow-on biologic -- by definition -- will not be the same as the innovative product, and thus, without data exclusivity, a follow-on manufacturer may produce a follow-on biologic that is 'similar enough' for regulatory approval purposes but different enough so as to avoid the innovator's patents" (CQ HealthBeat, 5/16).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Sanofi Aventis Invests 100 Million Euros In New Facility In Mexico To Produce Seasonaland Pandemic Influenza Vaccine
19 Mar 2009
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY), announced the signing of an agreement with the Mexican authorities to build a 100 million euro facility to manufacture influenza vaccine in Mexico...


Running Tips
Running Tips

Beginning a running program may seem daunting at first, but it is a gradual process. Fitness expert Jonathan Cane provides tips for beginning runners.

more videos are available in our health videos section.